Company
Pairidex
Reducing Uncertainty in the Care and Treatment of Blood Cancer
Also known as PAIRIDEX INC.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- St. Louis, Missouri, United States
- Legal name
- PAIRIDEX INC.
Claim, correct or request removal
Record updated 18 September 2026
About
For patients with gene fusion-driven leukemia, FusionMRD™ is a personalized digital PCR assay designed for individualized monitoring of treatment response and long-term disease surveillance.
Funding snapshot
- Total raised
- $4.9MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Seed, $4.9M2026-07-27
Funding rounds
- Seed
- $4.9M2026-07-27, Company stated
- Round, 2026
- 2026-02-23
- Round, 2024
- $1.1M2024-05-15, SEC form D sold, 16 investors
Products
- Other
- FusionMRD™
Loading relationship preview